ask="N/A"
ask_size="N/A"
average_daily_volume="32764"
bid="3.00"
bid_size="1000"
book_value="3.34"
change="-0.02"
change_from_200_day_moving_average="1.35"
change_from_50_day_moving_average="1.17"
change_from_52_week_high="-1.84"
change_From_52_week_low="4.43"
change_in_percent="-0.25%"
close="7.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="686000"
high="8.05"
high_52_weeks="9.79"
last_trade_date="2/1/2017"
last_trade_price="7.95"
last_trade_size="100"
last_trade_time="3:59pm"
low="7.31"
low_52_weeks="3.52"
market_capitalization="169.18M"
moving_average_200_day="6.60"
moving_average_50_day="6.78"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.24"
open="8.18"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+20.45%"
percent_change_from_50_day_moving_average="+17.18%"
percent_change_from_52_week_high="-18.77%"
percent_change_from_52_week_low="+125.85%"
previous_close="7.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.39"
price_per_sales="32.62"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.92"
stock_exchange="NMS"
symbol="NBRV"
volume="22765"
weeks_range_52="3.52 - 9.79"
